Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Res Vet Sci ; 94(3): 701-6, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23261153

ABSTRACT

Conventional Single Photon Emission Computed Tomography (SPECT) precludes a detailed evaluation of the subcortical region. Micro-SPECT (µ-SPECT) has a higher resolution, but has not been used to evaluate the dog's brain until now. In this study, µ-SPECT of the brain was evaluated in 10 Beagle dogs. Magnetic Resonance Imaging (MRI) of the brain was used to draw a new region map containing 19 volumes of interest (VOIs). Semi-quantitative analysis of the µ-SPECT data was performed and the regional cerebral perfusion was represented by the perfusion indices (PIs). The highest perfusion was found in the parietal cortex and the lowest in the piriform cortex. An asymmetry toward the left hemisphere in general and a regional asymmetry in the frontal, temporal and parietal cortex were found. This study shows that functional imaging of the canine brain is possible using µ-SPECT and it describes the normal regional brain perfusion in the adult Beagle dog.


Subject(s)
Brain/diagnostic imaging , Cerebrovascular Circulation , Tomography, Emission-Computed, Single-Photon/veterinary , Animals , Brain/blood supply , Dogs , Magnetic Resonance Imaging/veterinary , Male , Neuroimaging/veterinary , Parietal Lobe/blood supply , Parietal Lobe/diagnostic imaging , Tomography, Emission-Computed, Single-Photon/methods
2.
Vet J ; 192(1): 81-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21636298

ABSTRACT

Brain perfusion can be investigated using single photon emission computed tomography (SPECT) and the intravenous injection of (99m)technetium ethyl cysteinate dimer ((99m)Tc-ECD). However, sedation using medetomidine, an α(2)-agonist, or anaesthesia using medetomidine and ketamine, an N-methyl-d-aspartate-(NMDA)-antagonist, may be required for SPECT studies in cats but can affect the regional cerebral blood flow (rCBF). The effects of medetomidine, with or without ketamine, on regional brain perfusion were therefore investigated in six cats under three conditions. Injection of tracer occurred before sedation or anaesthesia (condition A), following intramuscular (IM) sedation with medetomidine (condition M) or after IM anaesthesia with medetomidine and ketamine (condition MK). Medetomidine and medetomidine with ketamine caused a significantly higher total tracer uptake in all brain regions. Semi-quantification of brain perfusion gave lower perfusion indices in several sub-cortical regions in conditions M and MK, compared to A. Left-right differences were observed in the temporal cortex (A), the temporal, parietal cortex and the thalamus (M) and the frontal cortex (MK). A significantly higher perfusion index in the sub-cortical regions, compared to the whole cortex, was only present in condition A. This study showed that caution is needed when quantifying brain perfusion indices when using sedative or anaesthetic agents that may affect rCBF.


Subject(s)
Anesthetics, Dissociative/administration & dosage , Cats/metabolism , Cerebrovascular Circulation/drug effects , Hypnotics and Sedatives/administration & dosage , Ketamine/administration & dosage , Medetomidine/administration & dosage , Animals , Blood Circulation Time/veterinary , Cross-Over Studies , Cysteine/analogs & derivatives , Drug Combinations , Female , Injections, Intramuscular/veterinary , Injections, Intravenous/veterinary , Magnetic Resonance Imaging/veterinary , Organotechnetium Compounds , Radiopharmaceuticals , Tomography, Emission-Computed, Single-Photon/veterinary
3.
J Comp Pathol ; 145(2-3): 199-206, 2011.
Article in English | MEDLINE | ID: mdl-21334003

ABSTRACT

Inflammatory bowel disease (IBD) is an idiopathic chronic inflammatory disease of the stomach, the small intestine and/or the large intestine. Loss of integrity of the intestinal barrier may be an important factor in the pathogenesis of IBD. In dogs, lymphoplasmacytic enteritis (LPE) is one of the recognized forms of IBD. P-glycoprotein (P-gp) is a membrane-bound efflux pump constituting an important component of the intestinal barrier. Changes in P-gp expression at the level of the intestinal barrier may be important in the pathogenesis of canine LPE, as this may lead to variable protection against xenobiotics and bacterial products in the intestine. The aim of the present study was to evaluate the expression of epithelial P-gp in the intestine in dogs with LPE compared with disease-free animals. Formalin-fixed intestinal biopsy samples from 57 dogs with histopathological evidence of LPE were immunolabelled with anti-P-gp antibodies (C494 and C219). Endoscopic biopsy samples of the duodenum and colon from 16 healthy beagles were used as controls. None of the control dogs had P-gp expression in the apical membrane of duodenal enterocytes, but all had P-gp labelling at the colonic epithelial surface. Twenty out of 57 dogs with LPE had P-gp expression at the apical surface membrane of villus epithelial cells in the duodenum, jejunum and/or ileum. Six out of 16 colonic samples from dogs with LPE had decreased P-gp expression at the epithelial surface compared with controls. It is unclear whether these changes in P-gp expression in dogs with LPE are a cause or a consequence of the inflammation. The observed changes could affect bioavailability of therapeutic drugs used in LPE.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis , Dog Diseases/metabolism , Enteritis/veterinary , Intestinal Mucosa/metabolism , Animals , Biopsy , Dog Diseases/pathology , Dogs , Duodenal Diseases/metabolism , Duodenal Diseases/pathology , Duodenal Diseases/veterinary , Enteritis/metabolism , Enteritis/pathology , Immunohistochemistry , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/pathology , Inflammatory Bowel Diseases/veterinary , Intestinal Mucosa/pathology
4.
Res Vet Sci ; 91(1): 138-143, 2011 Aug.
Article in English | MEDLINE | ID: mdl-20800859

ABSTRACT

Sedatives and anaesthetics are known to cause changes in the regional cerebral blood flow. In dogs intramuscular sedation with medetomidine, a potent sedative frequently used in veterinary medicine, is sometimes indicated prior to intravenous injection of (99m)Technetium-Ethyl Cysteinate Dimer ((99m)Tc-ECD) in brain perfusion studies using Single Photon Emission Computed Tomography (SPECT). Based on the knowledge of the distribution of alpha(2)-receptors in the brain, we hypothesized altered regional brain perfusion in dogs receiving medetomidine prior to (99m)Tc-ECD. Two conditions were compared in 10 dogs; tracer injection before and after intramuscular sedation with medetomidine. In our study, medetomidine caused a significantly higher tracer uptake in all brain regions. Semi-quantification of brain perfusion rendered a lower perfusion index in the subcortical region and an imbalance between left and right cortical perfusion induced by medetomidine. This study shows that caution is needed when quantifying the brain perfusion indices under medetomidine sedation.


Subject(s)
Cerebrovascular Circulation/drug effects , Cysteine/analogs & derivatives , Hypnotics and Sedatives/pharmacology , Medetomidine/pharmacology , Organotechnetium Compounds , Radiopharmaceuticals , Animals , Dogs , Drug Administration Schedule/veterinary , Female , Hypnotics and Sedatives/administration & dosage , Male , Medetomidine/administration & dosage , Tomography, Emission-Computed, Single-Photon/veterinary
5.
J Vet Med A Physiol Pathol Clin Med ; 54(6): 292-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17650148

ABSTRACT

The objective of this study was to investigate if cellular reactivity to collagen type I exists in dogs with unilateral cranial cruciate ligament (CrCL) rupture and if it relates to disease progression. The patient group consisted of 10 dogs with unilateral CrCL rupture. The control dogs consisted of three healthy control dogs, and two healthy dogs with unilateral sham operations of the stifle joint. All dogs were assayed repeatedly every 6 months for 12-24 months. Peripheral blood mononuclear cells were isolated from whole blood and were cultured with human collagen type I at concentrations of 5, 20 and 40 microg/ml for 6 and 7 days. Lymphocyte reactivity to collagen type I occurred not only in dogs with CrCL rupture, but also in sham-operated dogs and healthy dogs. Five of the eight assays (63%) performed at the time of operation or at the time of diagnosis of CrCL rupture had a stimulation index (SI) >or=3.0. This was not significantly different compared to healthy control dogs, not to the sham-operated control dogs. The CrCL rupture was assessed intraoperatively in six cases. Three cases had partial rupture and three had complete rupture. Only one dog with partial rupture, and two dogs with complete rupture had a positive SI. An increase in proliferation to collagen type I was seen in dogs with CrCL rupture, whereas it either remained stable or decreased in the control dogs. No distinct pattern in lymphocyte reactivity to collagen type I could be established from the dogs that sustained a CrCL rupture in the contralateral stifle joint, although most dogs that did not sustain a CrCL rupture in the contralateral stifle joint remained negative during this study with exception of one dog. Further research is required to determine whether cellular reactivity to collagen type I may play an initiating role in cruciate degradation.


Subject(s)
Anterior Cruciate Ligament/immunology , Anterior Cruciate Ligament/pathology , Collagen Type I/immunology , Lymphocytes/physiology , Stifle/immunology , Animals , Anterior Cruciate Ligament/surgery , Cell Division , Dogs , Female , Male , Rupture, Spontaneous/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...